The annual AusBiotech conference has been bringing together Australian and international biotech leaders and stakeholders for more than three decades, creating a forum to reflect on the sector’s achievements and exchange ideas to further advance the sector’s standing both nationally and globally.
AusBiotech is dedicated to consolidating this growth, and the 2018 conference will once again present issues critical to industry. Global biotech trends, breakthroughs, challenges and success stories will feature prominently on the program. Panel discussions and key themes will cover regulation and reimbursement, research translational strategies, new markets, business development and capital access, emerging technologies, clinical trials, regenerative medicine, agriculture and commercialisation.
COO, Tom Mander and Head Business Development (AsiaPacific), Tifelle Reisinger will be at the event - you can find them at booth 33 in the exhibition. Come along and discuss how Domainex can support your drug discovery programme.